Pablo Bifani

Dr. Bifani is a principal investigator at A*STAR ID Labs at their Antimicrobial Resistance Lab. He has extensively researched antimicrobial resistance in tuberculosis and malaria. He is also an associate professor and research director at the Yong Yoo Lin School of Medicine, National University of Singapore.

Dr. Bifani is a principal investigator at A*STAR ID Labs at their Antimicrobial Resistance Lab, with a focus on understanding molecular mechanisms of drug resistance in pathogens and identifying better screening assays for drug discovery. He has extensively researched antimicrobial resistance in tuberculosis and malaria. He is also an associate professor (Department of Microbiology and Immunology) and research director (Translational Research Programme in Infectious Diseases) at the Yong Yoo Lin School of Medicine, National University of Singapore.

Selected news links:

Asia's race to outsmart antimicrobial resistance - Asia Research News, March 8, 2022
The Disease Hunters Episode 3: Mosquito Mayhem TVO Today, Jun 16, 2021
When the medicine doesn’t work any more: Looking for new weapons against diseases - CNA Insider, Dec 26, 2020

Selected publications

Researchgate
Google Scholar
Ward KE, Christensen P, Racklyeft A, Bifani P. et al. Integrative genetic manipulation of Plasmodium cynomolgi reveals MultiDrug Resistance-1 Y976F associated with increased in vitro susceptibility to mefloquine. The Journal of Infectious Diseases. (2022) DOI: 10.1093/infdis/jiac469
Christensen P, Racklyeft A, Bifani P, et al. Improving in vitro continuous cultivation of Plasmodium cynomolgi, a model for P. vivax. Parasitol Int. (2022) DOI: 10.1016/j.parint.2022.102589